Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for GoodRx Holdings, Inc. (GDRX : NSDQ)
 
 • Company Description   
GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

Number of Employees: 697

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.57 Daily Weekly Monthly
20 Day Moving Average: 954,917 shares
Shares Outstanding: 342.57 (millions)
Market Capitalization: $1,222.99 (millions)
Beta: 1.69
52 Week High: $4.05
52 Week Low: $1.77
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 7.53% 6.82%
12 Week 10.87% 4.57%
Year To Date 31.73% 16.25%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2701 OLYMPIC BOULEVARD
-
SANTA MONICA,CA 90404
USA
ph: 855-268-2822
fax: -
ir@goodrx.com http://www.goodrx.com
 
 • General Corporate Information   
Officers
Wendy Barnes - Chief Executive Officer and President
Trevor Bezdek - Chairman
Christopher McGinnis - Chief Financial Officer
Romin Nabiey - Chief Accounting Officer
Christopher Adams - Director

Peer Information
GoodRx Holdings, Inc. (CHCR)
GoodRx Holdings, Inc. (ESRX)
GoodRx Holdings, Inc. (MYDP)
GoodRx Holdings, Inc. (COR)
GoodRx Holdings, Inc. (GBCS)
GoodRx Holdings, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 38246G108
SIC: 7374
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/03/26
Share - Related Items
Shares Outstanding: 342.57
Most Recent Split Date: (:1)
Beta: 1.69
Market Capitalization: $1,222.99 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.04 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.16 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 12.96% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/03/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 23.03
Trailing 12 Months: 23.80
PEG Ratio: 1.78
Price Ratios
Price/Book: 1.89
Price/Cash Flow: 8.92
Price / Sales: 1.56
EPS Growth
vs. Year Ago Period: -20.00%
vs. Previous Quarter: 33.33%
Sales Growth
vs. Year Ago Period: -1.31%
vs. Previous Quarter: 3.30%
ROE
09/30/26 - -
06/30/26 - 7.22
03/31/26 - 7.90
ROA
09/30/26 - -
06/30/26 - 2.53
03/31/26 - 3.23
Current Ratio
09/30/26 - -
06/30/26 - 1.38
03/31/26 - 1.47
Quick Ratio
09/30/26 - -
06/30/26 - 1.38
03/31/26 - 1.47
Operating Margin
09/30/26 - -
06/30/26 - 5.72
03/31/26 - 6.22
Net Margin
09/30/26 - -
06/30/26 - 2.07
03/31/26 - 2.61
Pre-Tax Margin
09/30/26 - -
06/30/26 - 5.27
03/31/26 - 5.78
Book Value
09/30/26 - -
06/30/26 - 1.89
03/31/26 - 1.82
Inventory Turnover
09/30/26 - -
06/30/26 - -
03/31/26 - -
Debt-to-Equity
09/30/26 - -
06/30/26 - 0.74
03/31/26 - 0.78
Debt-to-Capital
09/30/26 - -
06/30/26 - 42.65
03/31/26 - 43.68
 

Powered by Zacks Investment Research ©